Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer.
Boyraz B, Sendur MA, Aksoy S, Babacan T, Roach EC, Kizilarslanoglu MC, Petekkaya I, Altundag K.
Boyraz B, et al. Among authors: sendur ma.
Curr Med Res Opin. 2013 Apr;29(4):405-14. doi: 10.1185/03007995.2013.775113. Epub 2013 Mar 1.
Curr Med Res Opin. 2013.
PMID: 23402224
Review.